tweetindex

Peter A. McCullough, MD, MPH® @P_McCulloughMD · 02 Sep 2026

EnteroMix: Promise and Peril in Russia’s Personalized Cancer Vaccine A Cautious Examination of the Dual-Platform Immunotherapy. URL TheFocalPoints. @McCulloughFund https://t.co/uKDqX3ZSfM
20 761Views
34Likes
9Reposts
3Replies
0Quotes
4Bookmarks

Is that a lot?

1.00×vs this author's median20 704 views is typical
57Percentile for this authorof 7 recent posts
0.86×vs 1M–10M median24 048 views is typical
1.65%Reachviews ÷ followers
0.22%Engagement rateof viewers reacted

Compare with the benchmark table →

Open on X →